Edition:
India

Alimera Sciences Inc (ALIM.OQ)

ALIM.OQ on NASDAQ Stock Exchange Global Market

1.28USD
23 Feb 2018
Change (% chg)

$0.03 (+2.40%)
Prev Close
$1.25
Open
$1.26
Day's High
$1.28
Day's Low
$1.21
Volume
22,789
Avg. Vol
24,508
52-wk High
$1.71
52-wk Low
$1.04

Chart for

About

Alimera Sciences, Inc. (Alimera) is a pharmaceutical company. The Company is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company operates through two segments: U.S. and International. The Company focuses on diseases affecting the back of the eye or retina. The... (more)

Overall

Beta: 2.27
Market Cap(Mil.): $95.64
Shares Outstanding(Mil.): 69.05
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.91 10.66
ROE: -- 16.41 14.30

BRIEF-Alimera Sciences Enters Into $40 Mln Term Loan Agreement With Solar Capital

* ALIMERA SCIENCES INC- ENTERED INTO A $40 MILLION TERM LOAN AGREEMENT WITH SOLAR CAPITAL LTD

08 Jan 2018

BRIEF-Alimera Sciences Inc reports qtrly loss per share ‍$0.08​

* Alimera Sciences Inc reports third quarter 2017 financial results

02 Nov 2017

BRIEF-Alimera Sciences files for mixed shelf of up to $100 mln‍​

* Alimera Sciences Inc files for mixed shelf of up to $100 million – SEC filing ‍​ Source text - (http://bit.ly/2yCWftF) Further company coverage:

23 Oct 2017

BRIEF-Alimera Sciences ‍announces Iluvien now available in Ireland​

* Alimera Sciences Inc - ‍Announces Iluvien now available in Ireland​ Source text for Eikon: Further company coverage:

13 Sep 2017

BRIEF-Alimera Sciences signs agreement for distribution of Iluvien in France

* Alimera Sciences signs agreement for exclusive distributor of Iluvien in France

30 Aug 2017

Competitors

Earnings vs. Estimates